Demetris D. Crum - 01 Jul 2025 Form 3/A - Amendment Insider Report for AbbVie Inc. (ABBV)

Role
EVP, Chief HR Officer
Signature
/s/ T.O. Odutayo, Attorney-in-Fact for Demetris D. Crum
Issuer symbol
ABBV
Transactions as of
01 Jul 2025
Net transactions value
$0
Form type
3/A - Amendment
Filing time
30 Jul 2025, 17:00:26 UTC
Date Of Original Report
11 Jul 2025
Next filing
20 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Crum Demetris D EVP, Chief HR Officer 1 NORTH WAUKEEGAN ROAD, NORTH CHICAGO /s/ T.O. Odutayo, Attorney-in-Fact for Demetris D. Crum 30 Jul 2025 0002078592

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ABBV Common stock, $0.01 par value 7,048 01 Jul 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ABBV Option (Right to buy) 01 Jul 2025 Common Stock 5,043 $175.28 Direct F2
holding ABBV Option (Right to buy) 01 Jul 2025 Common Stock 4,687 $192.86 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,113 restricted stock units granted under the AbbVie Amended and Restated 2013 Incentive Stock Program. These restricted stock units vest in full on February 16, 2026, and include the right to have stock withheld for tax purposes.
F2 Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 1,681 shares on 2/15/2025, and will become exercisable as to 1,681 shares on 2/15/2026 and as to 1,681 shares on 2/16/2027.
F3 Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option will become exercisable as to 1,563 shares on 2/13/2026, as to 1,562 shares on 2/13/2027 and as to 1,562 shares on 2/13/2028.

Remarks:

This Form 3/A amends the original Form 3 filed on July 11, 2025, which reported Mr. Crum's initial holdings using the Issuer's CIK as an interim measure, pending receipt of Mr. Crum's personal CIK codes. This Form 3/A now utilizes Mr. Crum's personal CIK codes, identifying him as the Reporting Owner, with no alteration to his beneficial ownership. Exhibit 24 - Power of Attorney